NDC 61474-4400-01: Acetaminophen, Doxylamine Succinate, Phenylephrine Hydrochloride 325 mg; 6.25 mg; 5 mg Capsule, Liquid Filled, Carton of 5,600
This is a package of 5,600 capsules of Acetaminophen, Doxylamine Succinate, Phenylephrine Hydrochloride 325 mg; 6.25 mg; 5 mg Capsule, Liquid Filled from Catalent Ontario Limited, first listed with the FDA May 2025 and currently FDA-listed. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 61474-4400-1 alone.
- Record
- FDA NDC Directory package listing · Drug for further processing
- Code segments
- 61474 labeler · 4400 product · 1 package
- Package marketed since
- May 30, 2025
- Listing certified through
- Dec 31, 2027
- Barcode (UPC-A, from the NDC)
- 3 6147444001 4
- FDA record last changed
- Sep 10, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
This is a liquid-filled capsule containing three active ingredients commonly combined in over-the-counter cold and flu products. Acetaminophen is typically used to reduce fever and relieve pain, while doxylamine succinate functions as a sedating antihistamine often included to promote sleep during illness. Phenylephrine hydrochloride is a decongestant commonly used to help relieve nasal congestion. The listing indicates this is a bulk or intermediate product intended for further processing rather than direct consumer use.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 61474-4400-01 You're viewing this Main listing | 5600 CAPSULE, LIQUID FILLED in 1 CARTON | — | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| NightTime Sinus 325 mg/1; 6.25 mg/1; 5 mg 53345-0031-01 | Humanwell | 4000 capsules | — | — | FDA listed | — |
| NightTime Sinus Relief 325 mg/1; 6.25 mg/1; 5 mg 53345-0013-01 | Humanwell | 4000 capsules | — | — | FDA listed | — |
| Acetaminophen, Doxylamine Succinate, Phenylephrine Hydrochloride 325 mg/1; 6.25 mg/1; 5 mgthis 61474-4400-01 | Catalent | 5600 capsules | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Catalent Ontario Limited labeler code 61474
- Diphenhydramine Hydrochloride 25 mg Capsule, Liquid Filled NDC 61474-4394-1
- Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride 5 mg; 10 mg; 325 mg Capsule, Liquid Filled NDC 61474-4395-1
- Acetaminophen, Guaifenesin, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride 5 mg; 10 mg; 325 mg; 200 mg Capsule, Liquid Filled NDC 61474-4396-1
- Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Phenylephrine Hydrochloride 10 mg; 325 mg; 6.25 mg; 5 mg Capsule, Liquid Filled NDC 61474-4397-1
- Acetaminophen, Guaifenesin, Phenylephrine Hydrochloride 325 mg; 5 mg; 200 mg Capsule, Liquid Filled NDC 61474-4398-1
- Acetaminophen, Phenylephrine Hydrochloride 325 mg; 5 mg Capsule, Liquid Filled NDC 61474-4399-1
- Acetaminophen, Guaifenesin 200 mg; 325 mg Capsule, Liquid Filled NDC 61474-4409-1
- Doxylamine Succinate 6.25 mg Capsule, Liquid Filled NDC 61474-4411-1
- Diphenhydramine Hydrochloride 25 mg Capsule, Liquid Filled NDC 61474-4417-1
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
Full FDA label FDA SPL
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
Reported adverse events (FAERS)
Top reported reactions
Reporter sex
Where does this data come from?
About this NDC listing & data coverage
What "drug for further processing" means
FDA lists this package under the "drug for further processing" marketing category: Catalent Ontario Limited supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |